April 24, 2018 09:46 AM EDT
News Briefing

Sofinno­va leads $32.4 mil­lion round for Italy's Ery­Del; Cel­gene ex­pands col­lab­o­ra­tion with Zymeworks

ENDPOINTS

→ Hav­ing fol­lowed Mi­lan-based Ery­Del and its CEO for years, Sofinno­va Part­ners is jump­ing in for the ride, lead­ing its lat­est €26.5 mil­lion ($32.4 mil­lion) …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

A service from the Financial Times